Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells
Yoshio Honma(National Cancer Center Hospital East), Ken‐ichi Asahi(RIKEN), Takeshi Sassa(Yamagata University), Yuki Ishii(University College London)
Cited by 33
Related Papers
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
|Proceedings of the National Academy of Sciences|1983|255
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
|Journal of Lipid Research|2004|156
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
|Biochemical and Biophysical Research Communications|1980|120
Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase
|Biochemical and Biophysical Research Communications|1992|110